Pulmonary Drug Delivery Devices Market Soars with Innovative Solutions

Global Pulmonary drug delivery devices market was valued at US $35.6 Bn in 2022 and is expected to reach US $48.5 Bn by 2030, growing at a CAGR of 5% during the forecast period 2023-2030
One of the key factors contributing to the growth of the Pulmonary Drug Delivery Devices market is the rising incidence of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). As the global population ages and environmental factors contribute to the increase in respiratory disorders, there is a growing demand for advanced drug delivery solutions. Pulmonary drug delivery offers several advantages, including rapid onset of action and reduced systemic side effects compared to traditional oral or intravenous administration.